Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0000950170-25-098771
Filing Date
2025-07-25
Accepted
2025-07-25 16:01:42
Documents
16
Effectiveness Date
2025-07-25

Document Format Files

Seq Description Document Type Size
1 S-8 acet-20250725.htm S-8 99695
2 EX-5.1 acet-ex5_1.htm EX-5.1 13301
3 EX-23.1 acet-ex23_1.htm EX-23.1 7278
4 EX-FILING FEES acet_exfilingfees.htm   iXBRL EX-FILING FEES 28540
5 GRAPHIC img18334421_0.jpg GRAPHIC 4682
6 GRAPHIC img208765579_0.jpg GRAPHIC 33344
  Complete submission text file 0000950170-25-098771.txt   326298

Data Files

Seq Description Document Type Size
18 EXTRACTED XBRL INSTANCE DOCUMENT acet_exfilingfees_htm.xml XML 7827
Mailing Address 131 DARTMOUTH STREET 3RD FLOOR BOSTON MA 02116
Business Address 131 DARTMOUTH STREET 3RD FLOOR BOSTON MA 02116 617-482-2333
Adicet Bio, Inc. (Filer) CIK: 0001720580 (see all company filings)

EIN.: 813305277 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-288953 | Film No.: 251151650
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)